top of page

Semaglutide Therapy in Austin TX

Semaglutide

(Injectable) is a human based- glucagon-like peptide-1 (GLP-1) receptor agonist prescribe as an adjunction to a reduced calorie diet and increased physical activity for chronic weight management in adult patient with an Initial Body Mass Index (BMI) that is considered outside a healthy range. Part of a Class of medication called GLP-1 receptor agonist, Semaglutide increase insulin secretion, which is good for diabetics. But in higher doses, it acts on centers in the brain and suppresses appetite. Used in conjunctions with diet and exercise, Semaglutide helps patients stick to a reduced-calories diet, enhancing the weight loss process.

Mechanism of Action

Stimulates glucose-dependent insulin release from pancreatic islets.
Slows gastric emptying
Inhibits inappropriate post-meal glucagon release, and reduces food intake.
 

Semaglutide Therapy

Potential Side Effects

The most common side effects may include nausea, diarrhea, vomiting, constipation, stomach pain, headache, fatigue, dizziness, bloating, gas and heartburn. More serious side effects may include; Pancreatitis, Gallbladder problems, Kidney problems/failure, serious allergic reactions, Increased heart rate, Depression.

Contraindications:

*Hypersensitivity to any glucagon-like peptide *Thyroid cancer/tumor

*Any type of endocrine (single or Multiple) Melanoma

Book Your Appointment Now

Appoved in 2021 by the FDA for chronic weight management in obese/overweight adults, this has been decribed as a "game changer"
"We have not seen this degree of weight loss with any previous medication, " Dr Timothy Garvey of the University of Alabama at Birmingham. According todata from trial results, more than 50 percent of trial participants lost 15 percent of their body weight, and anywhere between a third and 40 percent of participants lost 20 percent of their body weight.

The public realizing that obesity is a disease is an important fact when it comes to attitudes regarding obesity and weight loss. According to Dr Garvey," Many people among the lay public and many health care professionals as well think about obesity primarily as a lifestyle choice, even today, despite our scientific understanding of obesity as a disease. That's why I think these trials as important."

bottom of page